Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
Go back to Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 17.55 +0.68 (4.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.87 | 52 Week High | $12.48 | |||
| Open | $17.01 | 52 Week Low | $1.60 | |||
| Day High | $17.62 | P/E | N/A | |||
| Day Low | $16.60 | EPS | $-6.33 | |||
| Volume | 267,435 | |||||

